The Microsatellite Instability (MSI) gold standard research tool is now an IVD assay. The OncoMate™ MSI Dx Analysis System is a CE-marked IVD Medical Device that leverages the same MSI loci relied on by clinical researchers for almost two decades. The improved system is a clinical diagnostic tool for determining a tumor’s MSI status. Knowing MSI status can guide immunotherapy decisions and assist in diagnosing hereditary cancer syndromes, like Lynch Syndrome.
A PCR-based fragment-sizing test, the OncoMate™ MSI Dx Analysis System encompasses a complete workflow, from DNA extraction to data analysis. It offers analytical sensitivity and unsurpassed specificity with a short turn-around time.
Learn more about OncoMateTM MSI Dx System:
